This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The biologics market is expected to grow to more than $670 billion(iv) by 2030, and for pharmaceutical companies developing these complex drugs, the BD Libertas Wearable Injector offers a customisable, patient-centric solution. Biologics Market Size – Industry Report on Share, Growth Trends & Forecasts Analysis (2025 – 2030).
AstraZeneca has announced $50bn investment plans in the US by 2030 for drug manufacturing, and research and development (R&D). It will also support our ambition to reach $80bn in revenue by 2030.” Credit: grandbrothers/Shutterstock.com. Give your business an edge with our leading industry insights.
Our dedicated and specialised commercial team will drive the launch of Tyzavan, ensuring its successful introduction and adoption in US hospitals.” With a shelf life of 16 months without the need for refrigeration, Tyzavan offers practical benefits for hospital storage.
manufacturing and research by 2030, with a focus on producing drug substances for chronic disease treatments. The post Virginia drug plant will be AstraZeneca’s largest appeared first on Becker's Hospital Review | Healthcare News & Analysis. AstraZeneca is investing $50 billion in U.S.
24 mega-selling drugs with combined annual sales exceeding $250 billion will lose patent protection by 2030 and will soon be open for generic manufacturing. per cent, API Pharma at 12.6 per cent vs 7.6 per cent and Diagnostics at 13.6 per cent vs 12.6 per cent in FY23-25.
billion square feet of healthcare space by 2030 and 2.9 million hospital beds to meet global standards. This year alone, we witnessed the demand for healthcare infrastructure skyrocket, with estimates indicating a need for an additional 1.3
India’s pharma industry is on an impressive growth trajectory, expected to reach $65 billion by 2024 and to double to $130 billion by 2030. Renowned as a comprehensive, one-stop destination for innovative, cost-effective solutions, the expo will be showcasing the pharmaceutical industry’s modernisation, innovation, and sustainability.
GlobalDatas report, Endometriosis Market Size and Trend Report, reveals that the endometriosis market size across the seven major markets* (7MM) is expected to achieve a compound annual growth rate of more than 9 per cent during 2020-2030. 7MM: The US, France, Germany, Italy, Spain, the UK and Japan.
Providence aims to become the best place to give and receive care by 2030, backed by a technology-enabled transformation strategy. Tracking progress and defining success Providence is finalizing short-term goals for 2027 as it tracks progress toward its 2030 vision. President and CEO Erik Wexler detailed the Renton, Wash.-based
The Healthy People 2030 initiative addresses structural health care inequalities and implements programs to ameliorate SDOH. Healthy People 2030. Impact of a combined pharmacist and social worker program to reduce hospital readmissions. REFERENCES 1. Social determinants of health. Accessed May 5, 2025. Res Social Adm Pharm.
Secondary outcomes included rates of specialist referrals and asthma-related emergency department (ED) visits or hospitalizations. Asthma exacerbations requiring acute care were rare but notable: 1 patient visited the ED, and 3 were hospitalized, all of whom were in the track 2 group. 2019;380:2020-2030. Accessed June 9, 2025.
In a Gilead statement, Université Paris Cité infectious diseases professor Jean-Michel Molina said: “These positive opinions from the CHMP are an important step toward a new HIV prevention option that could help meet the diverse needs of people across Europe and aim at helping end new HIV infections by the EU target of 2030.
By 2025, over 71 million Americans (26% of the population) are expected to use RPM services, with the US market projected to double to $29+ billion by 2030. RPM delivers proven clinical benefits: reducing hospital admissions by 38% and ER visits by 51% , with patient satisfaction exceeding 90%. billion by 2030 with 12.8%
With annual growth projected at 36% through 2030 and 10 to 20 new approvals expected each year, oncology pharmacists are likely to encounter these therapies more frequently across care settings. 2-4 In the United States, the FDA had approved 44 cell therapy products as of March 6, 2025.
million deaths in 2019, and this is predicted to increase to approximately 23 million annual deaths by 2030. A steady increase in CVD-related deaths resulted in approximately 18.6 1 CVDs are disorders affecting the heart and blood vessels. Subscribe Now!
Furthermore, by 2030, the proportion of aging among PLWH are set to increase across geographic regions and gender. 1 The panel of presenters each tackled a different clinical consideration for PLWH, discussing weight management, cardiovascular risk, considerations for viral hepatitis spread, and aspects of healthy aging, respectively.
Robert Barrie July 4, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Only 4% of global drugs sales in 2030 will have patent protection. A recent report by GlobalData projects that the share of global drug sales under patent protection will decline by 2030. LanKS via Shutterstock.
EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
The goal is to take annual bilateral trade between the two nations to $500 billion by 2030 from the current $190 billion. Leyla Hasanzadeh June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Tech transfer for manufacturing purposes in India will be difficult if Trump imposes import duties on pharmaceuticals.
The new pre-procedure coordination assistant at New York City-based Mount Sinai Hospital’s cardiac catheterization lab may not be human, but she knows how to communicate like one. Projections from various government agencies indicate that by 2030, this shortage will worsen. “She has a soft, calm voice.
Hikma Commits $1 Billion to Boost US Drug Manufacturing and R&D Services by 2030 Nicholas Saraceno, Editor July 3rd 2025 Article The company joins a wave of global pharma companies reshoring operations to strengthen the US supply chain and meet patient needs through domestic innovation and capacity.
RPM investments projected to exceed $29 billion by 2030 , healthcare executives are demanding clinically validated solutions that streamline billing and maintain unwavering CMS alignment. Is your Remote Patient Monitoring (RPM) program delivering measurable clinical outcomes, audit-ready compliance, and scalable ROI?
The World Health Organization (WHO) has set a global goal to have 90% of girls fully vaccinated with the HPV vaccine by 2030. The vaccine also provides cross-protection against multiple high-risk HPV types beyond those directly targeted.
Both companies plan to further innovate partnerships within the medical industry’s digital landscape, aiming to improve patient outcomes and also contribute towards achieving national Healthy China 2030 objectives. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Chugai president and CEO Dr Osamu Okuda stated: “We believe that open innovation with external partners, including leading global players, is extremely important for achieving global first-class drug discovery outlined in our growth strategy toward 2030, TOP I 2030. “By Give your business an edge with our leading industry insights.
The global RSV market is set to reach $6.3bn in value by 2030, according to analysis by GlobalData. Around 64 million people of all ages globally every year are impacted by RSV, a common respiratory virus that causes seasonal infections such as the flu. It is also a leading cause of pneumonia and death in infants and older adults.
GlobalData’s Pharma Intelligence Center forecasts global sales for the drug to peak in 2030, generating $7bn in revenue. With entry to the market, Imfinzi stands alone as the only perioperative immunotherapy for muscle-invasive bladder cancer. Give your business an edge with our leading industry insights.
. “The label expansion for Mavyret, coupled with the implementation of ‘test and treat’ models of care, serves as a tool to support the public health community in treating more patients and bringing us closer to achieving the global 2030 elimination goal.” Give your business an edge with our leading industry insights.
As hospitals and health systems push to reduce friction in clinical workflows, EHR optimization has become mission-critical. The post 7 leaders on how EHRs must evolve by 2030 appeared first on Becker's Hospital Review | Healthcare News & Analysis.
The study projects that if the funding interruption persists, Mozambique could see a 15% rise in HIV infections and a 10% increase in HIV-related deaths by the year 2030. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
The study authors noted that an estimated 1 billion individuals are expected to have obesity by 2030. Obesity is defined as a body mass index (BMI) of 30.0 and higher.
He said that number has grown to approximately 400 residents and fellows, with expectations to expand to between 900 and 1,000 by 2030. “Frankly, hospitals are facing one of the largest healthcare cuts we’ve seen in our history,” he said. So, it’s certainly an ‘and’ strategy.”
The group had set a fundraising target of $11.9bn for its 2026-2030 budget. Robert Barrie June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Gavi conducted a fundraiser at its annual Global Summit held in Brussels on 25 June. The organisation raised more than $9bn, less than it had targeted.
Becker’s is proud to spotlight outstanding chief experience officers who are making a meaningful impact on the patient experience at hospitals and health systems nationwide. Vice President and Chief Experience Officer of Dayton (Ohio) Children’s Hospital. He also formerly worked as chief of staff for the Miami-Dade County commissioner.
So far in 2025, Becker’s has reported on nine health systems that unveiled or advanced hospital projects worth $1 billion or more. Three of the projects involve new hospital campuses in California. based Wellstar Health System filed a certificate-of-need application for a $1 billion hospital in Acworth, Ga. Marietta, Ga.-based
The American College of Emergency Physicians predicted in a 2021 study that there would be a surplus of nearly 8,000 emergency physicians by 2030. While much of the health care workforce is battling staff shortages, the emergency medicine field is trying to figure out how to manage a potential oversupply of physicians. Read the rest…
In the same statement, Pfizer also announced it has signed a pledge by the US Department of Health and Human Services (HHS) that calls on US healthcare system stakeholders such as hospitals, health systems, payers, suppliers and pharmaceutical companies to reduce GHG emissions and build a more climate resilient healthcare infrastructure.
The Bureau of Labor Statistics projects that the employment of pharmacists will increase by 3% from 2020 to 2030. Pharmacists can work in a variety of settings, including hospitals, community pharmacies, research laboratories, and government agencies. For example, they can become clinical pharmacists and work in hospitals.
According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Moreover, it’s estimated that nearly 90% of all large hospitals are already operating their own specialty pharmacies.
According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Moreover, it’s estimated that nearly 90% of all large hospitals are already operating their own specialty pharmacies.
208 patients were recruited at 10 hospitals in the Democratic Republic of the Congo (DRC) and Guinea. In alignment with the World Health Organization (WHO) Neglected Tropical Diseases Roadmap strategy, which aims to eliminate sleeping sickness by 2030.
The entire APAC region already accounts for 30% of all global pharma spending, and within these markets national healthcare expenditure is expected to increase threefold to over $2 trillion by 2030. million in 2030. New cancer cases in China increased from 4 million in 2015 to 4.4 million in 2019, and are estimated to increase to 5.7
According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Moreover, it’s estimated that nearly 90% of all large hospitals are already operating their own specialty pharmacies.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content